Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox??/Asasantin??) in France

Marissal, Jean-Pierre; Selke, Bernard

doi:10.2165/00019053-200422100-00004

Cited by 12 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… estimated the 5‐year cost of caring for incident strokes at €4156 billion in stroke units and €3718 billion in conventional units. The 1‐year cost for the healthcare system was estimated at €17 800 per patient in 2000 . The 1998 burden of cerebrovascular diseases in France was estimated at €2.2 billion (2007€) using a top‐down approach to attribute a portion of national healthcare expenditures to cerebrovascular diseases .…”

Section: Introductionmentioning

confidence: 99%

Cost of stroke in France

Chevreul

Durand‐Zaleski

Gouépo

et al. 2013

Euro J of Neurology

View full text Add to dashboard Cite

With healthcare costs representing 3% of total health expenditure in France, stroke constitutes an ongoing burden for the health system and overall economy. Nursing care added nearly half again the amount spent on healthcare, while productivity losses were more limited because nearly 80% of acute incident strokes were in patients over age 65. The high cost of illness underscores the need for improved prevention and interventions to limit the disabling effects of stroke.

show abstract

Section: Introductionmentioning

confidence: 99%

Cost of stroke in France

Chevreul

Durand‐Zaleski

Gouépo

et al. 2013

Euro J of Neurology

View full text Add to dashboard Cite

show abstract

“…10,11,15 Such studies have been the basis for many important cost-effectiveness analyses for stroke prevention and treatment modalities. [16][17][18] Childhood stroke cost data, however, are limited: there has been one published US cost analysis from a single children's hospital. 19 The costs of neonatal stroke have yet to be addressed.…”

mentioning

confidence: 99%

The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort

et al. 2010

View full text Add to dashboard Cite

show abstract

“…[11][12][13] Additional studies of adult stroke care have developed projections of expenditures at national levels to inform national health policymakers. 14 -16 Cost-effectiveness analyses of adult stroke care have been used to guide the selection of treatments such as anticoagulation in nonrheumatic atrial fibrillation, 17 antiplatelet therapy, 18 acute thrombolysis, 19 and the use of early discharge and stroke team coordination. 20 Taken together, the adult studies demonstrate that the analysis of stroke-care costs can provide guidance for the development of healthcare policy and help guide the selection of treatments.…”

mentioning

confidence: 99%

The Cost of Pediatric Stroke Care and Rehabilitation

Zamel

Ponnappa

et al. 2008

Stroke

View full text Add to dashboard Cite

Background and Purpose-There is little data regarding the cost of pediatric stroke care or the elements that contribute to these costs. We examined costs for poststroke care during the first year after diagnosis and compared these costs with the volume of the cerebral infarct and the level of neurological and functional outcome. Methods-We identified 39 children who sustained nontraumatic ischemic or hemorrhagic strokes and confirmed the diagnoses by review of medical and radiology records. Medical costs were tabulated for the year after the diagnosis of stroke. Cerebral infarct volumes were measured from MRI or CT scans. Neurological outcome was assessed by telephone with a modification of the Pediatric Stroke Outcome Measure (PSOM), and functional outcomes were assessed with a standardized quality-of-life measure. Results-The median cost for poststroke care during the year after diagnosis was $42 338 for the entire group. The cost for stroke care was higher for hemorrhagic stroke than for ischemic stroke. Cost had a significant positive correlation with neurological impairment. The modified PSOM score positively correlated with impairments of physical, emotional, social, and school function. Conclusions-The cost of stroke care may be one measure of stroke severity, with more extensive strokes resulting in greater medical costs. In addition, stroke appears to impair children's social ability along with their neurological function. (Stroke. 2008;39:161-165.)

show abstract

Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox??/Asasantin??) in France

Cited by 12 publications

References 13 publications

Cost of stroke in France

Cost of stroke in France

The 5-year direct medical cost of neonatal and childhood stroke in a population-based cohort

The Cost of Pediatric Stroke Care and Rehabilitation

Contact Info

Product

Resources

About